Prestige Consumer Healthcare
PBH
#4630
Rank
A$3.43 B
Marketcap
A$72.57
Share price
1.36%
Change (1 day)
-28.84%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2026 (TTM): A$5.87

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is A$5.48. In 2025 the company made an earnings per share (EPS) of A$5.30 a decrease over its 2024 EPS that were of A$5.98.

EPS history for Prestige Consumer Healthcare from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$5.8710.73%
2025A$5.30-11.4%
2024A$5.98-367.08%
2023A-$2.24-138.33%
2022A$5.8411.7%
2021A$5.2313.6%
2020A$4.61-651.67%
2019A-$0.83-148.78%
2018A$1.71-83.29%
2017A$10.24437.23%
2016A$1.91-34.13%
2015A$2.8952.94%
2014A$1.89-8.11%
2013A$2.06
2011A$1.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.16 121.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
A$9.73 77.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$9.77 78.17%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.82-66.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.02-8.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
A$8.60 56.85%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
A$3.21-41.37%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.41-1.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
A-$41.22-851.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
A$1.70-69.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel